Concepedia

Hedda Wold

HW

Statistics

Publications

2

Citations

119

H-Index

2

Active since

2014

Affiliations

Lytix Biopharma (Norway)(Current)

Hedda Wold is an author at Lytix Biopharma (Norway) specializing in methicillin-resistant staphylococcus aureus infection treatment, antimicrobial resistance, and antibiotic resistance.

Publications per year

2014–2017

2

Publications

2

LTX-109 Is a Novel Agent for Nasal Decolonization of Methicillin-Resistant and -Sensitive Staphylococcus aureus

Anna Nilsson, Håkan Janson, Hedda Wold et al. · Antimicrobial Agents and Chemotherapy · 2014 · 99 citations · Full text

, , +12

Postantibiotic effect and postantibiotic sub-MIC effect of LTX-109 and mupirocin on <i>Staphylococcus aureus</i> blood isolates

Louis D. Saravolatz, Joan Pawlak, Hayley Martin et al. · Letters in Applied Microbiology · 2017 · 20 citations

, , +15

1–2 of 2